New York (www.aktiencheck.de) - Rating-Update:
Akash Tewari, Analyst von Jefferies & Co, stuft die Aktie von Regeneron Pharmaceuticals (ISIN: US75886F1075,…
Fenimore, Christopher R. - Vorstand - Tag der Transaktion: 2023-03-23...…
Yancopoulos, George - Vorstand - Tag der Transaktion: 2023-03-23...…
Bassler, Bonnie L. - Aufsichtsrat - Tag der Transaktion: 2023-03-24...…
The "Halftime Report" traders give their top picks to watch for the second half....…
Sanofi, Regeneron, AbbVie, Roche and Eli Lilly are included in this Analyst Blog....…
The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease....…
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the Phase 3 trial of Dupixent (dupilumab), developed with Sanofi (NASDAQ: SNY), for uncontrolled chronic…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron (REGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…
Health Care Down as Sanofi, Regeneron Rise -- Health Care Roundup...…
Sanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say "exceeded…
Regeneron released positive phase 3 trial results for its therapy Dupixent....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Coinbase, Chewy, Regeneron, Accenture and First Republic were some of the most active shares on Thursday....…
Shares of Regeneron Pharmaceuticals Inc. REGN rallied about 7% in premarket trading on Thursday after the company said a pivotal…
Von Adria Calatayud PARIS (Dow Jones)--Sanofi hat einen Studienerfolg mit seinem gemeinsam mit Regeneron Pharmaceuticals entwickelten Medikament Dupixent zur…
PARIS (dpa-AFX) - Sanofi S.A. (SNYNF) and Regeneron Pharmaceuticals, Inc. (REGN) on Thursday said late-stage study of their Dupixent for…
Regeneron (REGN) gets FDA approval for Evkeeza to treat children aged 5 to 11 with homozygous familial hypercholesterolemia....…
WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc. (REGN) said that the U.S. Food and Drug Administration has approved Evkeeza (evinacumab-dgnb) to…
Regeneron: FDA Extends Evkeeza Approval to Children Ages 5 to 11 >REGN...…
Regeneron (REGN) closed the most recent trading day at $759.76, moving +0.07% from the previous trading session....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
...PARIS, March 21 (Reuters) - Healthcare companies Sanofi
and Regeneron......…
Regeneron (REGN) has had a good run in the past 12 months and the momentum should continue in 2023 on…
In the latest trading session, Regeneron (REGN) closed at $760.30, marking a -0.85% move from the previous day....…
$250,000 top award goes to Neel Moudgal in the nations oldest and most prestigious science and math competition for high…
Toronto (www.aktiencheck.de) - Rating-Update:
Brian Abrahams, Analyst vom Investmenthaus RBC Capital Markets, belässt die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…
Eylea, the companys top-selling blockbuster, isnt going away soon....…
Regeneron (REGN) closed the most recent trading day at $743.75, moving -0.19% from the previous trading session....…
Regeneron and Sarepta Therapeutics have been on fire so far this year....…
Sanofis (SNY) sBLA seeking label expansion of drug Dupixent for chronic spontaneous urticaria accepted by the FDA...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Regeneron: CHMP Backs Libtayo/Chemotherapy Combo in Advanced Non-Small Cell Lung Cancer...…
San Francisco (www.aktiencheck.de) - Rating-Update:
Mohit Bansal, Analyst von Wells Fargo Advisors, stuft die Aktie von Regeneron Pharmaceuticals Inc. (ISIN: US75886F1075,…
First-to-market Regeneron/Sanofis Dupixent (dupilumab) sees strong uptake in Eosinophilic Esophagitis (EoE) since its May 2022 FDA approval, according to findings…
Regeneron Gets FDA Priority Review of Pozelimab in Chaple >REGN...…
Cigna, Regeneron, Centene, and six other healthcare stocks have seen short interest drop by at least 40% recently. Fewer investors…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Goldstein, Joseph L. - Aufsichtsrat - Tag der Transaktion: 2023-02-06...…
Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-02-06...…
Landry, Robert E. - Vorstand - Tag der Transaktion: 2023-02-03...…
Bassler, Bonnie L. - Aufsichtsrat - Tag der Transaktion: 2023-02-03...…
NEW YORK, Feb. 6, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CTLT, TSLA, IDXX, XOM, and REGN. Click…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Mccourt, Marion - Vorstand - Tag der Transaktion: 2023-02-01...…
Ryan, Arthur F. - Aufsichtsrat - Tag der Transaktion: 2023-02-01...…
Gewinnmitnahmen haben zum Wochenschluss die jüngste Rally der US-Technologiewerte ausgebremst. Für Ernüchterung sorgten enttäuschende Quartalsberichte zweier Schwergewichte der Tech-Branche. Hinzu…
While the top- and bottom-line numbers for Regeneron (REGN) give a sense of how the business performed in the quarter…
Regeneron (REGN) tops earnings and sales estimates for the fourth quarter. However, sales of the lead drug Eylea decline year…